Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence

Research in animals and humans has associated Alzheimer’s disease (AD) with decreased cerebrospinal fluid levels of insulin in combination with decreased insulin sensitivity (insulin resistance) in the brain. This phenomenon is accompanied by attenuated receptor expression of insulin and insulin-lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Freiherr, Jessica, Hallschmid, Manfred, Frey, William H., Brünner, Yvonne F., Chapman, Colin D., Hölscher, Christian, Craft, Suzanne, De Felice, Fernanda G., Benedict, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709085/
https://www.ncbi.nlm.nih.gov/pubmed/23719722
http://dx.doi.org/10.1007/s40263-013-0076-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709085/
https://www.ncbi.nlm.nih.gov/pubmed/23719722
http://dx.doi.org/10.1007/s40263-013-0076-8

Ejemplares similares